← Back to Search

Shade + app with messaging for Skin Cancer

N/A
Waitlist Available
Research Sponsored by University of Minnesota
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks (post intervention)
Awards & highlights

Study Summary

This trial will test whether a wearable device that tracks sun exposure and provides alerts will increase sun protection behaviors in melanoma survivors.

Eligible Conditions
  • Skin Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks (post intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks (post intervention) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sun protection habits index
Secondary outcome measures
Self-report of sunburn in the past 12 weeks (Glanz et al., 2008)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Shade and application with UV message activatedExperimental Treatment1 Intervention
wearable device (wrist) and associated mobile application; UV sensor exposure display and messaging activated
Group II: Shade and application without UV messagingActive Control1 Intervention
wearable device (wrist) and associated mobile application; UV sensor exposure display and messaging not activated
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Shade + app with messaging
2020
N/A
~370

Find a Location

Who is running the clinical trial?

Melanoma Research AllianceOTHER
7 Previous Clinical Trials
158 Total Patients Enrolled
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,089 Total Patients Enrolled
University of MinnesotaLead Sponsor
1,375 Previous Clinical Trials
1,588,007 Total Patients Enrolled

Frequently Asked Questions

~76 spots leftby Apr 2025